Senior Human Resource Business Partner
Voy
Senior Human Resource Business Partner
Voy
Personalized weight-loss program with meds
Voy is a healthcare platform led by clinicians. We support people managing long-term health conditions with treatment plans backed by real evidence.
Founded in 2018, we started as MANUAL, focusing on hair loss, weight loss and men’s health. As we grew, we realised we could help more people. In 2025, we became Voy and expanded into more areas of health, including female hair loss, testosterone, menopause, dermatology and diagnostics with Do Health.
Today, Voy has around 750,000 active customers and has treated more than 2 million people since we began. We work across the UK, Germany, Brazil and India to make a new future of healthcare a reality. We’re approaching $1bn in ARR and have grown more than 100% year on year, every year since inception. At Voy, we let the evidence do the talking. In a published study of over 100,000 people, those who reached 12 months in the Voy programme and stayed engaged lost up to 24% of their body weight.
Our vision is simple: to make 100 years of healthy living within reach for everybody. Our mission is to bring quality care to everyone, at scale.
About Voy
Voy is one of the largest DTC online healthcare providers in the world. Present in the UK, Germany, Brazil and India. Voy entered India through the 100% acquisition of EarlyFit, which was started in 2025 by two passionate co founders who spent 6 years in New York and witnessed first-hand the power of GLP-1s and how it grew from a niche solution to over 10cr real users worldwide. EarlyFit started as India’s first full-stack tech-led GLP-1 led weight loss platform. At the intersection of healthcare, science, and consumer technology, we combined GLP 1, medical expertise, endocrinologist-led care, diagnostics, nutrition coaching, and ongoing behavioral support into one seamless experience.
About the space
GLP-1s represent a quantum leap in healthcare (think penicillin!) and possibly the biggest healthcare opportunity of our lifetimes. The GLP market went from 0 to $60B in just 8 years and estimated to grow to $200B in the next 10. Several multi-billion dollar companies like Voy, Found, Ro and Hims and Hers have ridden this wave that’s only just arrived in India with the 2025 launch of Mounjaro and Ozempic. We’re 8 years behind the US and Europe (which is super frustrating but also…) means there is a unique opportunity to category create in a white space (think Paytm for mobile wallets) and in the process, give 10+ years of healthy life to each patient we onboard. Sure, we have some catching up to do but the Indian GLP space has something the West doesn’t - Generics. The patent for semaglutide (Ozempic) in India expired in March 2026 bringing monthly medication prices from Rs 20k a month to Rs 3k a month. With 250 million obese Indians who can now suddenly afford life-changing medical help that’s never existed in the country before, you do the math.
What You'll Do ?
What you bring ?
Voy helps people lose weight by combining medical treatment with ongoing behavioral coaching. It runs a weight‑loss program where clients start with an online assessment to identify a personalized plan, then receive prescribed medication delivered discreetly to their home, plus regular coaching sessions to monitor progress and reshape eating habits. The approach also tackles emotional eating and aims for long‑term results, supported by a subscription model that provides continuous care. Compared with traditional dieting, Voy emphasizes medically guided weight management and sustained support, which it says leads to much greater total weight loss over time. The company’s goal is to help clients achieve durable health improvements by pairing personalized care, medical treatment, and habit change.
Explore more opportunities at Voy